Even though the sample size was very small, they demonstrated the ability of 68Ga-Pentixafor PET/CT to detect all schwannomas with sufficient tumour to background and tumour to blood pool ratios that matched with membranous CXCR4 expression as assessed by immunohistochemistry [78]. The gene discussed is CXCR4; the disease is neoplasm.